“Efficacy and Safety of Tyrosine Kinase 2 Inhibitor Deucravacitinib in Psoriasis : A Systematic Review and Drug-Response Meta Analysis of RCTs”. 2025. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, December, 10. https://doi.org/10.53366/jimki.vi.961.